GGrantIndex
← Leaderboards

Michael George Aman

Ohio State University

$6,533,883
Attributed
$6,533,883
Total exposure
12
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $902.7K · FY200512
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$6,533,883 · 12

By mechanism

R01$3,704,668 · 2
U10$2,432,555 · 1
N01$299,199 · 1
M01$97,461 · 8

Top collaborators

No co-investigators on record.

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Behavior Therapy

Research focus

Behavior TherapyRisperidoneFollow-UpChildParentsTrainingPharmaceutical PreparationsSafetyPlacebo ControlSymptomsProceduresAttention Deficit Hyperactivity DisorderAdverse EventPlacebosOutcome MeasureResponseAntipsychotic AgentsAnalogCognitiveBehaviorDouble-Blind MethodExhibitsTeacherHuman Subject

Grant awards (28)

2/3-Atomoxetine Placebo and Parent Training in Autism$350,730
R01 · FY2012 · MH · contact PI
1/4-Stimulant and Risperidone for Youth with Severe Physical Aggression$504,579
R01 · FY2011 · MH · contact PI
2/3-Atomoxetine Placebo and Parent Training in Autism$356,865
R01 · FY2011 · MH · contact PI
1/4-Stimulant and Risperidone for Youth with Severe Physical Aggression$518,208
R01 · FY2010 · MH · contact PI
2/3-Atomoxetine Placebo and Parent Training in Autism$361,873
R01 · FY2010 · MH · contact PI
1/4-Stimulant and Risperidone for Youth with Severe Physical Aggression$525,826
R01 · FY2009 · MH · contact PI
2/3-Atomoxetine Placebo and Parent Training in Autism$358,106
R01 · FY2009 · MH · contact PI
1/4-Stimulant and Risperidone for Youth with Severe Physical Aggression$18,752
R01 · FY2009 · MH · contact PI
1/4-Stimulant and Risperidone for Youth with Severe Physical Aggression$365,909
R01 · FY2008 · MH · contact PI
2/3-Atomoxetine Placebo and Parent Training in Autism$343,820
R01 · FY2008 · MH · contact PI
CLINICAL TRIAL: RISPERIDONE AND BEHAVIOR THERAPY IN CHILDREN WITH PDD$9,355
M01 · FY2008 · RR · contact PI
RISPERIDONE AND BEHAVIOR THERAPY IN CHILDREN WITH PDD$32,668
M01 · FY2007 · RR · contact PI
RUPP-PI Project$466,452
U10 · FY2006 · MH · contact PI
RISPERIDONE AND BEHAVIOR THERAPY IN CHILDREN WITH PDD$22,592
M01 · FY2006 · RR · contact PI
PHARMACOGENETICS OF RISPERIDONE IN CHILDREN WITH PDD$2,568
M01 · FY2006 · RR · contact PI
RUPP-PI Project$485,117
U10 · FY2005 · MH
RISPERIDONE AND BEHAVIOR THERAPY IN CHILDREN WITH PDD$14,006
M01 · FY2005 · RR
RISPERIDONE PHARMACOKINETICS IN CHILDREN WITH AUTISM$1,168
M01 · FY2005 · RR
RUPP-PI Project$488,162
U10 · FY2004 · MH
MHP in the treatment of hyperactivity and impulsiveness$11,479
M01 · FY2004 · RR
Risperidone &9-hydroxyrisperidone in saliva and plasma$3,625
M01 · FY2004 · RR
RUPP-PI Project$488,639
U10 · FY2003 · MH
RUPP-PI Project$504,185
U10 · FY2002 · MH
RESEARCH UNITS ON PEDIATRIC PSYCHOPHARMACOLOGY--AUTISM$299,199
N01 · FY2000 · MH
RESEARCH UNITS ON PEDIATRIC PSYCHOPHARMACOLOGY--AUTISM$0
N01 · FY2000 · MH
DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF RISPERIDONE$0
M01 · FY2000 · RR
RESEARCH UNITS ON PEDIATRIC PSYCHOPHARMACOLOGY--AUTISM$0
N01 · FY2000 · MH
DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF RISPERIDONE$0
M01 · FY2000 · RR